ALLMedicine™ Dry Eye Syndrome Center

Jan 26th, 2023 - Fuchs Endothelial Corneal Dystrophy (FECD) is the most common corneal endothelial disorder and has been estimated to affect approximately 4% of the US population over the age of 40. Corneal transplantation is currently the primary treatment modali...

Jan 22nd, 2023 - As digital display devices become more and more indispensable, associated health problems have started to increase. We aimed to investigate the frequency and relationship of digital display device usage behaviours and dry eye syndrome (DES) in med...

Jan 3rd, 2023 - Microbial keratitis (MK) is an ophthalmological emergency that can lead to sight threatening complications such as corneal scarring, perforation, endophthalmitis and ultimately blindness. The patient requires aggressive topical antimicrobial thera...

Dec 30th, 2022 - To investigate the accompanying ocular findings in patients with obstructive sleep apnea syndrome (OSAS) and evaluate the susceptibility to ophthalmological diseases. In this cross-sectional study, qualifying study subjects were patients who had b...

Dec 23rd, 2022 - The aim of the study is to demonstrate the non-inferiority of Eyestil Plus® compared to Vismed Multi® in terms of clinical performance as detected by a reduction of keratitis lesions objectified by staining tests after 1 month of treatment, in pat...

Oct 28th, 2018 - Dry Eye Syndrome Preferred Practice Pattern®.|2018|Akpek EK,Amescua G,Farid M,Garcia-Ferrer FJ,Lin A,|organization & administration,therapeutic use,diagnosis,drug therapy,therapeutic use,organization & administration,analogs & derivatives,therapeu...

Jan 26th, 2023 - Fuchs Endothelial Corneal Dystrophy (FECD) is the most common corneal endothelial disorder and has been estimated to affect approximately 4% of the US population over the age of 40. Corneal transplantation is currently the primary treatment modali...

Jan 3rd, 2023 - Microbial keratitis (MK) is an ophthalmological emergency that can lead to sight threatening complications such as corneal scarring, perforation, endophthalmitis and ultimately blindness. The patient requires aggressive topical antimicrobial thera...

Dec 23rd, 2022 - Multicenter, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group, Phase 2 clinical trial. The study objective is to evaluate the safety and efficacy of two different concentrations (0.5% and 1%) of progesterone topical gel compared to pl...

Dec 23rd, 2022 - The aim of the study is to demonstrate the non-inferiority of Eyestil Plus® compared to Vismed Multi® in terms of clinical performance as detected by a reduction of keratitis lesions objectified by staining tests after 1 month of treatment, in pat...

Dec 22nd, 2022 - Method: This study wants to evaluate the Chinese herbal tea VGH-DESJS-1 on Nourishing Yin and Moistening Dryness the ocular dryness from dry eye syndrome (DES) and Sjögren's syndrome (SJS). One hundred dry eye subjects are composed of 30 dry eye s...

Nov 10th, 2022 - Dry eye disease (DED), also known as dry eye syndrome, keratoconjunctivitis sicca (KCS), and keratitis sicca, is a multifactorial disease of the ocular surface due to a loss of homeostasis of the tear film. It often results in ocular symptoms and ...

Aug 26th, 2022 - Stress, anxiety, depression, SARS-CoV-2 infections and deaths, dry eye syndrome, and gastrointestinal diseases feature among the problems that medical interns have reported. These problems result from the workload they experience during their clin...

Apr 4th, 2022 - Transcript: Yi-Bin Chen, MD: Many of the patients I see in my clinic are afflicted with chronic graft-vs-host disease, and it’s the most important determinant of long-term quality of life. When we talk about chronic graft-vs-host disease in studi...

Aug 17th, 2021 - Belantamab mafodotin-blmf (Blenrep) has elicited significant responses in patients with relapsed/refractory multiple myeloma, but the corneal toxicities associated with its use will require a multidisciplinary effort between ophthalmologists and h...

Nov 25th, 2020 - Another use for the intense pulsed-light device, pulsed-dye laser, and potassium titanyl phosphate laser in clinical practice is for treating patients who have dry eye, even if you are not an ophthalmologist, suggests R. Rox Anderson, MD.